Home › Cardiovascular Disease › North Carolina › Asheville
Cardiovascular Disease clinical trials in Asheville, NC
4 studies for Cardiovascular Disease are looking for participants at sites in and around Asheville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Asheville Cardiology Associates Research Department, Asheville
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RecruitingPhase 4Healthy volunteers welcome
- Asheville VA-Charles George VA Medical Center, Asheville
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Asheville
Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs
Recruiting
- Mission Health, Asheville
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC28 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- Nashville, TN18 studies
Other studies in Asheville
- Heart Failure7 studies
- Non-Small Cell Lung Cancer5 studies
- Acute Lymphoblastic Leukemia4 studies
- Acute Myeloid Leukemia4 studies
- Chronic Lymphocytic Leukemia4 studies
- Burkitt Lymphoma4 studies
- Lung Cancer4 studies
- Acute Biphenotypic Leukemia3 studies
- Melanoma3 studies
- Graves Disease3 studies
- Hyperthyroidism3 studies
- Colorectal Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.